Track record · closed signal

Hims & Hers Health, Inc. (HIMS) — closed signal from January 3, 2026

Partial Published before the outcome was known, scored automatically when the window closed on April 3, 2026.

Predicted vs. what happened

HIMS price · publication thesis → realized outcomesplit-adjusted

$31.00 – $33.75Entry zone — fair-value band

$33.41Published — price the day we called it

$42.10Target — the price the thesis aimed for

$36.45Peak — highest point inside the window, not a realized return

$19.14Window close — end-of-window price, context only

What happened

Partial

Reached 35% of the predicted growth at its peak, without hitting the target.

Peak price

$36.45

peak on January 7, 2026 — not a realized return

Peak gain

+9.1%

peak, from the publication price

Window close

$19.14

end-of-window price, context only

Days to target

—

Window

January 3, 2026 – April 3, 2026

The thesis — published January 3, 2026

Predicted growth

+26%

over the measurement window

Target price

$42.10

the price the thesis aimed for

Entry zone

$31.00 – $33.75

the fair-value band we waited for

Price at publication

$33.41

published January 3, 2026

Confidence

66%

how strongly the data lined up

Timeframe

Short-term (0–3 months)

This is a risky short-term trade that can move a lot in either direction. The company is seen by some as much cheaper than it should be, which could attract buyers, but market sentiment and trading flows are mixed and many traders are betting against it. That combination can cause sudden rallies or sharp selloffs, so tight risk control is essential.

Primary drivers

Seen as trading nearly half below fair value, suggesting upside
Many traders are betting against the stock, which can spark fast rallies
Buying interest in momentum can support recoveries if a stable base forms
Subscription telehealth business can continue to grow revenues over time

How it played out

HIMS: thesis missed after early 9.1% peak

Lyra published HIMS at $33.41 on January 3, 2026, with expected growth of 26% and a $42.10 target. The thesis pointed to a risky short-term setup. It cited a stock seen as cheaper than fair value, heavy bets against it, possible momentum buying if a base formed, and revenue growth from a subscription telehealth business.

Inside the window, HIMS rose to $36.45 on January 7, a 9.1% peak gain. It never reached $42.10. By April 3, it ended at $19.14. The early rally partly matched the setup, but the published target was missed and the full thesis did not play out.

What happened during the window

On February 19, 2026, Hims & Hers announced an agreement to acquire Eucalyptus. On April 3, 2026, TechRadar reported that Hims & Hers had disclosed a cyberattack tied to customer support tickets accessed between February 4 and February 7, 2026.

Prices are shown split- and dividend-adjusted, matching what public charts show today.

Lyra

Read the next call before it closes.

This is one signal, scored after the fact. Today’s picks come with the same plain-language thesis — published before anyone knows the outcome.

See today’s picks All HIMS signals